GlassScriptPhysician profile
Christopher K Sanborn
NPI 1225186877
$8,020.65
in general payments reported to CMS, 2019-2025
26 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,095 · 2020: $333 · 2021: $337 · 2022: $178 · 2023: $466 · 2024: $1,408 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,138 · Travel and Lodging: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.90 |
| Travel and Lodging | $939.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,944.84 | 2019-2024 | Da Vinci Surgical System |
| Apollo Endosurgery US INC | $522.91 | 2019 | |
| Ethicon US, LLC | $348.33 | 2019-2024 | Echelon Endopath |
| Novo Nordisk INC | $279.71 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Intra-Sana Laboratories | $140.03 | 2023-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| W. L. Gore & Associates, INC. | $89.68 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Medical Device Business Services, INC. | $85.11 | 2021 | |
| Medtronic, INC. | $62.99 | 2021-2024 | Ligasure |
| Shire North American Group INC | $61.74 | 2019 | |
| Abbott Laboratories | $56.33 | 2022-2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $47.92 | 2024-2025 | Zepbound |
| Shield Therapeutics INC | $41.33 | 2025 | |
| Phathom Pharmaceuticals, INC. | $38.70 | 2024-2025 | Voquezna |
| Microline Surgical INC | $37.38 | 2024 | |
| Daiichi Sankyo INC. | $36.82 | 2023 | Injectafer |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $30.46 | 2024 | Titan Sgs |
| Hologic Sales and Service, LLC | $25.33 | 2022 | |
| Conmed Corporation | $23.53 | 2024 | Airseal |
| Olympus America INC. | $22.99 | 2023 | Olympus |
| Pacira Pharmaceuticals Incorporated | $22.22 | 2022 | |
| Ambu INC. | $21.26 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.54 | 2023 | Gattex |
| Rhythm Pharmaceuticals, INC. | $20.42 | 2024 | Imcivree |
| Zealand Pharma US, INC. | $14.88 | 2022 | |
| Baxter Healthcare | $13.47 | 2022 | |
| Endo Pharmaceuticals INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sanborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.